About your Search

20121006
20121014
Search Results 0 to 8 of about 9 (some duplicates have been removed)
. it is really that simple. mitchell: "the nonpartisan tax policy center concluded that mitt romney's tax plan would cost $4.8 trillion over 10 years." vo: why won't romney level with us about his tax plan, which gives the wealthy huge new tax breaks? because according to experts, he'd have to raise taxes on the middle class - or increase the deficit to pay for it. if we can't trust him here... how could we ever trust him here? oh, hey alex. just picking up some, brochures, posters copies of my acceptance speech. great! it's always good to have a backup plan, in case i get hit by a meteor. wow, your hair looks great. didn't realize they did photoshop here. hey, good call on those mugs. can't let 'em see what you're drinking. you know, i'm glad we're both running a nice, clean race. no need to get nasty. here's your "honk if you had an affair with taylor" yard sign. looks good. [ male announcer ] fedex office. now save 50% on banners. [ male announcer ] fedex office. why they have a raise your rate cd. tonight our guest, thomas sargent. nobel laureate in economics, and one of the most cited eco
tax cut. that's not my plan." mitchell: "the nonpartisan tax policy center concluded that mitt romney's tax plan would cost $4.8 trillion over 10 years." vo: why won't romney level with us about his tax plan, which gives the wealthy huge new tax breaks? because according to experts, he'd have to raise taxes on the middle class - or increase the deficit to pay for it. if we can't trust him here... how could we ever trust him here? >>> it is time. it is time for the "lightning round." on cramer's you say the name -- >> buy, buy, buy! >> sell, sell, sell! >> when i play this sound -- [ buzzer ] >> -- and then the "lightning round" is over. are you ready, skee-daddy? let's start with dave in michigan. dave? >> caller: hey, jim, big detroit tiger boo-yah to you. >> nice. good luck. what is up? >> caller: hey, jim, agnc. i've got it in my retirement fund, and it's been dropping like a rock. and they're saying it's because of qe3. what do you think? >> look, there are issues involving the fact that these particular mortgage real estate investment trusts should not do as well in this particul
in the limited partnerships, high yield without tax headaches. do you recommend picking up some of linn? >> you know, when i first looked at it it was terrific. i wanted to see where it was priced, where it trades. i don't want to say, yeah, it's good or bad. these are about price. as i have learned too well with some of them that were -- that looked cheap for me but it turned out to be overprized. let me come back. john in oregon, please. john? >> caller: hey, jim. boo-yah from western oregon. i have a question about the home construction. do you think the nice ride that we have had on residential construction is over with or not? >> this is a group and i was doing work on toll brothers. they have big spurts, then slam downs. everyone says it's over in the slam down and you should be a buyer not a seller. you want to get it, try these hot list momentum stocks. remember, no guarantee they won't go down. . >> announcer: lightning round is sponsored by td ameritrade. [ bell ringing ] >> it is time. it is time for the lightning round. you say the name of the stock. i don't know the calls or the na
of extra goodies, like tax incentives, years of marketing exclusive ift, but best of all, when you have awe drug that treats an ultra rare often lethal condition with no known cure like alexion does, there's basically no limit on how much you can charge for the thing. after all, what price can you put on a human life? alexion is working hard to answer that question because solaris may be the single most expensive drug on earth. a year of treatment can cost more than a half a million dollars. that's why even though not very many people have the blood disorder, solaris is already a billion dollar drug, and at the end of last year it got fda approval for an extremely rare kidney disease that can be deadly. ever since solaris got fda approval back in 7dz, it has been beating the street's expectation. how big could the drug be? for pnh solaris could be $2 billion in sales around the world. this kidney disease could mean an additional $900 million in sales, and plus a treatment for a number of other diseases, and the data on each of these are pretty darn good. altogether they could be worth as mu
Search Results 0 to 8 of about 9 (some duplicates have been removed)